Table 1

Baseline characteristics of participants

CON group
n=35
AT group
n=35
Variables at baselineMean (SD) or
n (%) or
median (IQR)
Mean (SD) or
n (%) or
median (IQR)
Descriptive variables and covariates
 Age, years73.7 (8.3)74.8 (8.4)
 Gender, female17 (49%)19 (54%)
 Education, >high school27 (82%)24 (69%)
 Functional Comorbidity Index2.8 (2.2)2.8 (1.5)
 Hypertensive, yes20 (61%)17 (49%)
 Mini-mental state examination26.4 (3.1)26.3 (2.7)
 Montreal cognitive assessment21.7 (4.4)20.7 (3.3)
 Waist-to-hip ratio0.93 (0.07)0.88 (0.08)
 Short physical performance battery10.51 (1.20)10.62 (1.86)
 Time-up-and-go (s)8.67 (2.26)8.82 (2.36)
 Physiological profile assessment0.94 (1.42)0.94 (1.39)
Medications
 Taking beta blockers, yes7 (20%)7 (20%)
 Central-effecting medications, no0.5 (1.0)0.6 (0.9)
 Total medications, no4.2 (3.4)3.5 (2.7)
Primary clinical and economic outcome variables
 Alzheimer's disease assessment scale, cognition10.2 (5.4)11.7 (5.5)
 Executive interview13.3 (6.4)13.7 (4.7)
 ADCS-ADL46.5 (5.1)46.1 (6.8)
 EQ-5D-3L (patient rated)0.797 (0.109)
 0.817 (0.135)
0.822 (0.072)
 0.826 (0.108)
 EQ-5D-3L (caregiver rated)0.799 (0.136)
 0.826 (0.117)
0.829 (0.064)
 0.843 (0.108)
Secondary outcome variables
 Stroop Test 3-2 (s)57.12 (24.13)67.82 (28.36)
 Trail making test B-A (s)75.18 (83.27)59.70 (42.28)
 Digit span forward—backward3.8 (1.95)3.37 (2.44)
 6-minute walk (m)486.9 (97.9)502.8 (98.4)
 Weight (kg)72.39 (14.11)70.05 (14.31)
 Body mass index26.54 (3.97)25.26 (3.54)
 Resting heart rate (bpm)70.24 (15.10)67.26 (12.38)
 Resting systolic blood pressure (mm  Hg)132.29 (18.66)139.80 (17.73)
 Resting diastolic blood pressure (mm  Hg)76.71 (11.38)80.26 (10.05)
 Physical activity scale for the elderly118.59 (55.41)124.44 (73.47)
  • AT, aerobic exercise training group; CON, nutrition education.